Stem Cell Therapy and Nanotechnology in Diabetes

A successful bone marrow or stem cell transplant may help slow or halt the progression of certain metabolic syndromes including type 1 diabetes, but early diagnosis is critical to prevent irreversible disease progression. Pancreatic islet allotransplantation is a procedure in which islets from the donor pancreas are transferred into another person to treat type 1 diabetes and have been a promising cellular-based therapy. The recent advances in nanomedicine include smart drugs which only activate when needed, nanoformulations for efficient drug delivery, engineered microbes which produce human hormones, and even nanorobots, which would move autonomously around the body acting as a boost, for our immune system, red blood cells, or many other biological systems.

  • Islet Cell Transplantation
  • Embryonic Stem Cells
  • Mesenchymal Stem Cell Therapy

Related Conference of Stem Cell Therapy and Nanotechnology in Diabetes

November 11-12, 2019

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
December 04-05, 2019

3rd Annual Congress on Diabetes and Its Complications

Tokyo, Japan
December 9,10,2019

International Congress and Expo on Diabetic Care

Bangkok,Thailand
December 12-13, 2019

Annual Congress on Diabetes and Endocrinology

Dubai, UAE
January 27-28, 2020

Global Summit On Diabetes & Endocrinology

Bangkok, Thailand
March 25-26, 2020

29th World Diabetes & Heart Congress

| Radisson Narita | Tokyo, Japan
March 27-28, 2020

Annual Summit on Metabolomics

Amsterdam, Netherlands
April 17-18, 2020

3rd Global Meeting on Diabetes and Endocrinology

Kualalumpur, Malaysia
June 15-16, 2020

29thEuropean Diabetes Congress

| Barcelona, Spain
August 17-18, 2020

16th World Congress on Endocrinology & Diabetes

| Copenhagen, Denmark
June 14-15, 2021

diabetic 2021

Abu Dhabi, UAE

Stem Cell Therapy and Nanotechnology in Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in